FDA Approves New Antibiotics as Breakthroughs in Gonorrhea Treatment
The article discusses the recent FDA approval of two new antibiotics for gonorrhea, highlighting the innovative, not-for-profit development model of zoliflodacin by GARDP, which aims to make essential antibiotics more accessible globally, especially in low- and middle-income countries, amidst rising antimicrobial resistance.